KPKalliopi Pazaitou-Panayiotou

Kalliopi Pazaitou-Panayiotou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kalliopi Pazaitou-Panayiotou has a total of 85 co-authors. Here are the top co-authors by number of shared publications:

  • Maria Boudina

    8 shared publications
  • Frideriki Patakiouta

    7 shared publications
  • Stylianos Mandanas

    Department of Endocrinology, Theagenio Cancer Hospital, Thessaloniki, Greece

    7 shared publications
  • Alexandra Chrisoulidou

    Department of Endocrinology and Endocrine Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece

    5 shared publications
  • Periklis Mitsakis

    Department of Endocrinology , Theagenio Cancer Hospital, 2, Al Simeonidi Street, 54007 Thessaloniki, Greece 2 Endocrinology Section , Internal Medicine Department, Nykobing Falster Hospital, Nykobing Falster, Denmark 3 Department of Pathology , Theagenio Cancer Hospital, Thessaloniki, Greece

    5 shared publications
  • Alexandra Chrisoulidou

    Theagenio Canc Hosp, Unit Endocrinol, Thessaloniki, Greece

    4 shared publications

Latest Publications

  • Chronic lymphocytic thyroiditis is associated with invasive characteristics of differentiated thyroid carcinoma in children and adolescents

    by Paschalia K Iliadou, Grigoris Effraimidis, Michalakis Konstantinos, Panagiotou Grigorios, Periklis Mitsakis, Frideriki Patakiouta, Kalliopi Pazaitou-Panayiotou

    Children and adolescents with CLT present more frequently familial PTC as well as thyroid cancer with invasive characteristics.


  • Diagnosis of papillary thyroid carcinoma: Is it time to reconsider?

    by Panagiotis Panousis, Stella Vasileiadou, Michael Katsamakas, Maria Boudina, Anastasia Nikolaidou, Alexandra Chrysoulidou, Kalliopi Pazaitou-Panayiotou, George Zafeiriou

    Aim: The aim of this retrospective study was to evaluate the diagnostic significance of presurgical thyroid ultrasound in comparison with FNAC of thyroid nodules and their contribution in detecting thyroid cancer. Patients and methods: We retrospectively studied the files of 118 thyroid cancer patients, 18 men (15.2%) and 100 women (84.8%), who underwent thyroidectomy from January 2013 until December 2016, in the Department of Surgical Oncology of Theagenio Cancer Hospital, Thessaloniki, Greece. All patients were diagnosed and followed up by the Section of Endocrinology and were operated upon by the same surgical team. The mean patient age was 55 years (±12.26). We evaluated the suspicious ultrasound findings according to the ATA Guidelines of 2015 (hypogenicity, microcalcifications, taller than wide shape, irregular margins, extrathyroidal extension) and the results of FNAC (in accordance to Bethesda Score), in association with the pathology report. All ultrasounds were scored based on the suspicious characteristics. Results: Mean tumor size was 7.1 mm (±8.73 mm), multifocallity was found in 69 patients (58.5%). The Bethesda score was positive for malignancy in 45% of the cases. On the other hand, the suspicious ultrasound findings were in accordance with the pathology report in 78.8% of the cases. Almost all patients with Bethesda II or III presented at least one or more suspicious ultrasound characteristics and those with Bethesda VI at least three or more suspicious for cancer ultrasonographic findings. Based on our statistical analysis, ultrasound as a diagnostic tool is more significant (P<0.05) and has a more positive predictive value in detecting thyroid cancer compared to FNAC. Conclusions: Ultrasound characteristics and clinical suspicion are considered more valuable in the diagnosis of papillary thyroid carcinoma, especially for small lesions (<10 mm) and multinodular goiter. Therefore, an ultrasound scoring system should be adopted by the clinicians coping with thyroid cancer.

  • Chronic lymphocytic thyroiditis is associated with invasive characteristics of differentiated thyroid carcinoma in children and adolescents

    by Paschalia K Iliadou, Grigoris Effraimidis, Michalakis Konstantinos, Panagiotou Grigorios, Periklis Mitsakis, Frideriki Patakiouta, Kalliopi Pazaitou-Panayiotou

    Background: The association between chronic lymphocytic thyroiditis (CLT) and thyroid cancer is an interesting topic. The aim of the present study was to evaluate if demographic and histological characteristics as well as the long-term outcome of thyroid cancer was different in children and adolescents with and without CLT.Methods: The medical records of children and adolescents (≤21 years old) were reviewed. The following data were recorded: gender, year and age at diagnosis, family history of thyroid cancer, history of external radiation therapy, histological type (papillary and variants, follicular and variants), tumour size, multifocality, infiltration of thyroid parenchyma or surrounding soft tissues, vascular invasion, presence of lymph node and distant metastases. Information about the presence of TgAb and TPOAb was also collected.Results: One hundred eight children and adolescents (median age 19.0, interquartile range 4.0 years) were diagnosed with differentiated thyroid carcinoma (DTC); 31 patients (28.7%) presented histological characteristics compatible with CLT. Infiltration of thyroid parenchyma was more frequent in patients with CLT compared to patients without (74.2% vs 48.1% respectively, P=0.024). Familial papillary thyroid carcinoma (PTC) was more frequent in patients with CLT compared to those without CLT (20.7% vs 2.8% respectively, P=0.009). There was no better outcome with respect to the presence of CLT or not.Conclusions: Children and adolescents with CLT present more frequently familial PTC as well as thyroid cancer with invasive characteristics.


  • Papillary Thyroid Carcinomas in Patients under 21 Years of Age: Clinical and Histologic Characteristics of Tumors ≤10 mm

    by Kalliopi Pazaitou-Panayiotou, Paschalia K. Iliadou, Stylianos Mandanas, Theofanis Vasileiadis, Periklis Mitsakis, Konstantinos Tziomalos, Maria Alevizaki, Frideriki Patakiouta


  • Breast metastasis from medullary thyroid carcinoma in a man

    by Stylianos Mandanas, Efterpi Margaritidou, Konstantinos Georgopoulos, Maria Boudina, Alexandra Chrisoulidou, Kalliopi Pazaitou-Panayiotou

    Introduction: Medullary thyroid carcinoma (MTC) originated from parafollicular C cells of the thyroid gland is a rare histological type of malignancy. Common sites of metastases are liver, lungs and bones, while metastases in other sites are extremely rare. Breast metastases from MTC are reported in 20 cases, and only in women. Case report: A 67-year-old man was presented after thyroidectomy for further evaluation and treatment. Histology was positive for MTC with extrathyroidal extension and bilateral cervical lymph node metastases. Postoperative calcitonin was 613.6 pg/ml (normal range <10 pg/ml) and RET protooncogene was found negative for multiple endocrine neoplasia. Computed tomography and bone scan revealed metastases to lung and bone. Administration of tyrosine kinase inhibitor (vandetanib) was decided which was soon stopped due to serious adverse events (thrombocytopenia, bleeding, and impaired renal function). Antimotility agents and somatostatin analogues (octreotide LAR 20 mg) were used to control diarrhea. Seven months later he presented a painful swelling of right breast. Breast ultrasound revealed the presence of multiple, solid masses in the right breast and mammography was suspicious of malignancy. Core needle biopsy was positive for metastases from the known MTC. Palliative external beam irradiation was decided with mild relief of pain. The patient succumbed 1 month later. A literature search was conducted. No other cases of breast metastases from MTC in men were found. Conclusion: This is the first reported case of breast metastasis from MTC in men. Breast masses in the course of MTC should be evaluated for metastases since the therapeutic approach is different from that of primary breast carcinoma. Palliative external radiation therapy should be considered for metastatic and lesion causing pain.

  • Does lymphocytic thyroiditis influence the histological characteristics and the course of thyroid carcinoma in children and adolescents?

    by Paschalia Iliadou, Stylianos Mandanas, Konstantinos Michalakis, Periklis Mitsakis, Frideriki Patakiouta, Kalliopi Pazaitou-Panayiotou

    Introduction: The aim of the present study was to evaluate if demographic and histological characteristics as well as the long-term outcome of thyroid cancer was different in children and adolescents with and without autoimmune thyroiditis taking into consideration that information in the literature is scarce. Methods: The medical records of children and adolescents (≤21-year-old) followed up in Theagenio Cancer Hospital due to histologically proven thyroid carcinoma were reviewed. The following data were recorded: year of diagnosis of thyroid cancer, age at diagnosis, gender, family history of thyroid cancer, history of external radiation therapy, histological type (papillary and variants, follicular, medullary and poorly differentiated), tumour size, multifocality, lymph node metastases, vascular invasion, infiltration of thyroid parenchyma or surrounding soft tissues and presence of distant metastases. Information about the presence of anti-Tg and anti-TPO was also collected. All histological material was reviewed by a second pathologist with special attention in order to identify findings of lymphocytic thyroiditis. Data analysis was performed using the statistical package SPSS. Results: One hundred and twelve children and adolescents (mean age 18.1±3.0 years) were diagnosed with thyroid cancer from 1980 to 2013. Histology revealed papillary thyroid carcinoma (PTC) in the majority of the cases (88.4%). Thirty two patients (28.6%) presented histological characteristics compatible with lymphocytic thyroiditis. No differences were found in anthropometric characteristics between patients with and without lymphocytic thyroiditis. Infiltration of thyroid parenchyma was more frequent in the Hashimoto thyroiditis group compared to patients without (75.0 vs 47.5% respectively, P=0.015). Familial PTC was more frequent in patients with lymphocytic thyroiditis compared to those without lymphocytic thyroiditis (22.2 vs 2.8% respectively, P=0.006). Conclusion: Children and adolescents with Hashimoto disease present more frequently familial PTC as well as thyroid cancer with invasive characteristics. Larger epidemiological studies are needed to confirm our results.

  • Thyroglossal duct cyst carcinomas: is there a need for thyroidectomy?

    by Alexandra Chrisoulidou, Paschalia K. Iliadou, Eleni Doumala, Lemonia Mathiopoulou, Maria Boudina, Maria Alevizaki, Frideriki Patakiouta, Ekaterini Xinou, Kalliopi Pazaitou-Panayiotou

    Thyroglossal duct cyst (TGDC) carcinoma is a rare entity and its management is controversial. The aim of this retrospective study was to: (a) identify patients with TGDC carcinoma followed up in our clinic and (b) study specific characteristics of the disease and their association with thyroid carcinoma. Medical files of patients with TGDC carcinoma were reviewed and tumour characteristics, lymph node metastases, treatment and follow-up were evaluated. A total of 6 patients, 4 females and 2 males, mean age 39.3 years (median 33.5), were treated for papillary thyroid carcinoma arising in a TGDC. Carcinoma of the thyroid gland was found simultaneously in 4 of these patients, while in one patient thyroid carcinoma developed 10 years after the diagnosis of TGDC carcinoma. A variable clinical picture and presentation was recorded. The most aggressive manifestation of the disease in terms of local infiltration, local recurrence and lymph node metastases was observed in our youngest patients. Long-term follow-up is necessary for patients with thyroid carcinoma arising in a TGDC. In view of the frequent co-existence of thyroid cancer in these patients, we would recommend detailed thyroid evaluation and, eventually, total thyroidectomy at initial diagnosis of TGDC carcinoma.


  • Predictive factors that influence the course of medullary thyroid carcinoma

    by Kalliopi Pazaitou-Panayiotou, Alexandra Chrisoulidou, Stylianos Mandanas, Konstantinos Tziomalos, Eleni Doumala, Frideriki Patakiouta


  • The Increase in Thyroid Cancer Incidence is not only due to Papillary Microcarcinomas: a 40-year Study in 1 778 Patients

    by K. Pazaitou-Panayiotou, P. Κ. Iliadou, A. Chrisoulidou, P. Mitsakis, E. Doumala, A. Fotareli, M. Boudina, L. Mathiopoulou, F. Patakiouta, K. Tziomalos

    Thyroid cancer incidence has been increased over the last decades. The aims of the present study were: (a) to identify a changing trend in thyroid cancer in Northern Greece, (b) to examine patients’ and tumoral characteristics and (c) to investigate the increase of papillary microcarcinomas and that of invasive or larger cancers. We retrospectively analyzed the records of 1 778 patients who were diagnosed with thyroid cancer between January 1971 and December 2010. The study period was divided into 4 decades: 1971–1980, 1981–1990, 1991–2000, 2001–2010. Patients were separated into 2 groups: in Group A we have included papillary thyroid microcarcinomas (PTM) and in Group B all cancers with diameter >10 mm as well as invasive cancers ≤10 mm. Patients diagnosed with thyroid cancer increased substantially per decade. The relative frequency of papillary thyroid cancer cases increased (from 60% up to 84.6% in the last decade) and follicular cancers decreased (from 40% down to 11.6%). During the study period, cancer size declined. Frequency of PTM (Group A) increased from 0% up to 19.3% in the last decade, but cancers of this group represent only a minority of total cancers. The increase of thyroid cancer in this cohort was mainly due to tumors larger than 1 cm and also to smaller in size but invasive thyroid tumors. This increase outnumbers the increase in papillary thyroid microcarcinomas.


  • Calcium homeostasis in women with non-metastatic breast cancer with osteoporosis after a single-dose of denosumab: a pilot study

    by Stylianos Mandanas, Konstantinos Toulis, Lemonia Mathiopoulou, Efterpi Margaritidou, Konstantinos Georgopoulos, Maria Boudina, Alexandra Chrisoulidou, Kalliopi Pazaitou-Panayiotou

    Introduction: Women with non-metastatic breast cancer form a distinct subpopulation in which calcium homeostasis in response to treatment with denosumab has not been extensively investigated. Methods: Female patients with osteoporosis, who were eligible for treatment with denosumab, were prospectively enrolled (2011–2012) and divided into two groups; Group A consisting of patients with either no history or benign diseases non affecting bone metabolism (n=24 controls) and Group B patients with non-metastatic breast cancer (n=18). Documentation of renal impairment, disorders of parathyroid function or the presence of bone metastases served as exclusion criteria. All patients were administered a single-dose of denosumab under standard calcium and vitamin D supplementation. Serum calcium, phosphorus, parathyroid hormone (iPTH) and 24 h urine calcium were measured at days 0, 7 and 180. Primary outcomes were the development of hypocalcaemia and secondary hyperparathyroidism. Results: At baseline, groups were comparable in age, calcium and iPTH levels. No events of hypocalcaemia were recorded. Overall, incidence of secondary hyperparathyroidism was found to be 45.5% one week after administration of denosumab. Interestingly, at day 180 incidence of secondary hyperparathyroidism was higher in Group B in contrast to the pattern recorded in controls, although not reaching statistical significance. At day 7, iPTH was found to be significantly higher only in controls (Wilcoxon Signed Rank test: P=0.013) compared to group-specific baseline values. At day 180, borderline increase in iPTH of Group B was noted (P=0.08), whereas iPTH returned to baseline in controls. Discussion: A pattern of delayed development of secondary hyperparathyroidism might be present in patients with non-metastatic breast cancer. It could be extrapolated that this finding might be associated with a partial functional defect in calcium sensing receptor, which has recently been implicated in the pathogenesis of breast cancer. The findings warrant further investigation.